[144] American Well Corporation SEC Filing

Rhea-AI Filing Summary

American Well Corporation (AMWL) filed a Form 144 disclosing a proposed sale of 26,500 Class A common shares through Morgan Stanley on the NYSE with an aggregate market value of $180,661.10. The filing lists total shares outstanding as 14,162,309 and shows the approximate date of sale as 09/03/2025.

The securities were acquired on 09/03/2025 via vesting of a restricted stock unit grant; the filer reports acquisition of 55,211 shares through that grant and indicates no securities sold in the past three months. The filing contains the standard Rule 144 attestation language and a signature block remarking criminal penalties for misstatement.

Insights

Securities Compliance Analyst

TL;DR: Routine Form 144 filing reporting a planned insider sale following RSU vesting; no prior sales in past three months.

The filing documents a proposed sale under Rule 144 of 26,500 Class A shares, stemming from an RSU vesting event on the same date. Key compliance items are present: broker identification (Morgan Stanley), exchange (NYSE), aggregate market value, and the Rule 144 representation that no undisclosed material adverse information is known. For compliance reviewers, the filing appears to meet disclosure requirements for a Rule 144 notice; the absence of recent sales simplifies aggregation calculations.

Equity Compensation Specialist

TL;DR: Transaction arises from RSU vesting; the holder acquired 55,211 units and plans to sell 26,500 shares.

The document shows the securities to be sold were acquired by vesting of restricted stock units on 09/03/2025. The filer acquired 55,211 shares via vesting and intends to sell 26,500, indicating a partial disposition of vested awards. No sales in the prior three months are reported, which may simplify Rule 144 volume calculations. The filing contains requisite broker and transaction timing details necessary for clearing and reporting such post-vesting dispositions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	Morgan Stanley 1 New York Plaza 38th Floor New York MA 10004	26500	180661.10	14162309	09/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	09/03/2025	Vesting of Restricted Share Unit Grant	American Well Corporation			55211	09/03/2025	Vesting of Restricted Stock Unit Grant

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AMWL's Form 144 disclose about the proposed sale?

The Form 144 discloses a proposed sale of 26,500 Class A common shares on the NYSE through Morgan Stanley with an aggregate market value of $180,661.10 and an approximate sale date of 09/03/2025.

How were the shares being sold by AMWL acquired?

The shares were acquired on 09/03/2025 through the vesting of a Restricted Stock Unit (RSU) grant from American Well Corporation; the filing shows 55,211 shares acquired by that vesting.

Does the filing report any securities sold in the past three months?

No. The Form 144 states "Nothing to Report" under securities sold during the past three months.

Which broker and exchange are named for the proposed sale?

The broker listed is Morgan Stanley (1 New York Plaza, 38th Floor) and the named exchange for the sale is the NYSE.

What representations does the filer make in the Form 144?

The filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed and includes standard attestation language regarding Rule 10b5-1 plans and criminal penalties for misstatements.